First Citizens Bank & Trust Co Has Decreased By $700,112 Its Edwards Lifesciences (EW) Stake; Last Week MEG Energy Corp. (TSE:MEG) Coverage

MEG Energy Corp. (TSE:MEG) Logo

Among 4 analysts covering Meg Energy Corp. (TSE:MEG), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Meg Energy Corp. had 39 analyst reports since July 29, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, February 10 report. Raymond James maintained MEG Energy Corp. (TSE:MEG) on Monday, June 6 with “” rating. TD Securities maintained it with “Speculative Buy” rating and $9 target in Friday, October 28 report. The firm has “Hold” rating given on Friday, March 24 by TD Securities. The company was maintained on Tuesday, June 28 by Desjardins Securities. The stock of MEG Energy Corp. (TSE:MEG) has “Outperform” rating given on Friday, February 5 by RBC Capital Markets. Scotia Capital maintained the stock with “Outperform” rating in Friday, July 29 report. TD Securities maintained the stock with “Speculative Buy” rating in Friday, July 15 report. The firm earned “Outperform” rating on Friday, April 29 by RBC Capital Markets. Scotia Capital maintained it with “Outperform” rating and $9 target in Friday, February 10 report. See MEG Energy Corp. (TSE:MEG) latest ratings:

21/12/2017 Broker: Barclays Capital Rating: Old Target: $6.00 New Target: $5.00 Target Down
27/10/2017 Broker: Barclays Capital Rating: Old Target: $5.00 New Target: $6.00 Target Up
27/10/2017 Broker: National Bank Canada Rating: Sector Perform Old Target: $4.75 New Target: $5.25 Target Up
17/10/2017 Broker: IBC Rating: Old Target: $4.50 New Target: $5.25 Target Up

First Citizens Bank & Trust Co decreased Edwards Lifesciences Corp (EW) stake by 67.88% reported in 2017Q4 SEC filing. First Citizens Bank & Trust Co sold 6,251 shares as Edwards Lifesciences Corp (EW)’s stock rose 22.78%. The First Citizens Bank & Trust Co holds 2,958 shares with $333,000 value, down from 9,209 last quarter. Edwards Lifesciences Corp now has $28.45B valuation. The stock decreased 2.92% or $4.07 during the last trading session, reaching $135.45. About 602,671 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 44.06% since April 2, 2017 and is uptrending. It has outperformed by 32.51% the S&P500.

MEG Energy Corp. develops and produces in situ oil sands in Alberta, Canada. The company has market cap of $1.34 billion. The firm is developing oil recovery projects that utilize steam assisted gravity drainage extraction methods. It has a 7.98 P/E ratio. It owns a 100% working interest in approximately 900 square miles of oil sands leases located in the southern Athabasca oil sands region of Alberta, as well as the Christina Lake project in the southern Athabasca oil sands region of Alberta.

It closed at $4.55 lastly. It is down 0.00% since April 2, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 28 analysts covering Edwards Lifesciences Corp (NYSE:EW), 22 have Buy rating, 1 Sell and 5 Hold. Therefore 79% are positive. Edwards Lifesciences Corp has $195 highest and $86 lowest target. $133.78’s average target is -1.23% below currents $135.45 stock price. Edwards Lifesciences Corp had 108 analyst reports since July 30, 2015 according to SRatingsIntel. BTIG Research upgraded the stock to “Buy” rating in Monday, April 4 report. The company was maintained on Monday, September 4 by Canaccord Genuity. The firm earned “Outperform” rating on Wednesday, October 26 by RBC Capital Markets. The stock of Edwards Lifesciences Corporation (NYSE:EW) earned “Overweight” rating by Morgan Stanley on Thursday, October 26. The rating was initiated by SunTrust with “Neutral” on Friday, January 8. The rating was maintained by RBC Capital Markets on Friday, February 2 with “Buy”. The rating was maintained by Citigroup with “Sell” on Wednesday, July 27. The firm earned “Sell” rating on Thursday, November 12 by Citigroup. The firm has “Buy” rating by Northland Capital given on Thursday, July 27. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Buy” rating given on Wednesday, October 11 by BMO Capital Markets.

Analysts await Edwards Lifesciences Corporation (NYSE:EW) to report earnings on April, 24. They expect $1.10 earnings per share, up 17.02% or $0.16 from last year’s $0.94 per share. EW’s profit will be $231.03 million for 30.78 P/E if the $1.10 EPS becomes a reality. After $0.94 actual earnings per share reported by Edwards Lifesciences Corporation for the previous quarter, Wall Street now forecasts 17.02% EPS growth.

First Citizens Bank & Trust Co increased Ubs Ag London Brh (AMU) stake by 145,617 shares to 281,498 valued at $4.88M in 2017Q4. It also upped Salesforce Com Inc (NYSE:CRM) stake by 4,580 shares and now owns 11,184 shares. Pepsico Inc (NYSE:PEP) was raised too.

Edwards Lifesciences Corporation (NYSE:EW) Ratings Chart